Alaunos Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Vieser Jaime | — | Award / Grant | 5,340 | $3.16 | $16,874 | 26,499 | Nov 21, 2025 |
| Postma Robert W | — | Award / Grant | 5,142 | $3.16 | $16,249 | 38,250 | Nov 21, 2025 |
| Jerman Michael Allen | — | Award / Grant | 4,183 | $3.16 | $13,218 | 4,183 | Nov 21, 2025 |
| Groenewald Ferdinand | Vice President of Finance | Award / Grant | 10,775 | — | — | 10,775 | Aug 18, 2025 |
| Postma Robert W | — | Award / Grant | 4,050 | — | — | 33,133 | Jul 3, 2025 |
| Vieser Jaime | — | Award / Grant | 3,400 | — | — | 21,159 | Jul 3, 2025 |
| Postma Robert W | — | Award / Grant | 20,804 | $2.92 | $60,748 | 29,083 | Apr 13, 2025 |
| Postma Robert W | — | Award / Grant | 20,804 | $2.92 | $60,748 | 29,083 | Apr 13, 2025 |
| Vieser Jaime | — | Award / Grant | 17,465 | — | — | 43,359 | Apr 13, 2025 |
| Vieser Jaime | — | Sale | 818 | $2.00 | $1,636 | 25,894 | Dec 31, 2024 |
| Boyle Kevin S. Sr. | Chief Executive Officer | Sale | 68,014 | $0.14 | $9,522 | 798,236 | Sep 1, 2023 |
| Postma Robert W | — | Purchase | 750,000 | $0.65 | $487,500 | 5,000,000 | Nov 29, 2022 |
| Vieser Jaime | — | Purchase | 1,250,000 | $0.65 | $812,500 | 1,250,000 | Nov 29, 2022 |
| Boyle Kevin S. Sr. | Chief Executive Officer | Tax Withholding | 18,750 | $2.41 | $45,188 | 866,250 | Aug 30, 2022 |
| Thistle Mary | — | Award / Grant | 40,000 | — | — | 45,000 | Jun 22, 2022 |
| Huang James | — | Award / Grant | 80,000 | — | — | 188,333 | Jun 22, 2022 |
| Postma Robert W | — | Award / Grant | 40,000 | — | — | 1,241,870 | Jun 22, 2022 |
| Thistle Mary | — | Award / Grant | 40,000 | — | — | 45,000 | Jun 22, 2022 |
| Huang James | — | Award / Grant | 80,000 | — | — | 188,333 | Jun 22, 2022 |
| Postma Robert W | — | Award / Grant | 40,000 | — | — | 1,241,870 | Jun 22, 2022 |
| Vieser Jaime | — | Award / Grant | 40,000 | — | — | 745,321 | Jun 22, 2022 |
| Bowden Christopher | — | Award / Grant | 40,000 | — | — | 44,167 | Jun 22, 2022 |
| Weis Holger | — | Award / Grant | 40,000 | — | — | 160,167 | Jun 22, 2022 |
| De Groot Eleanor | EVP, Operations | Sale | 20,132 | $1.27 | $25,568 | 237,106 | Dec 22, 2021 |
| Boyle Kevin S. Sr. | Chief Executive Officer | Purchase | 9,116 | $1.40 | $12,762 | 885,000 | Nov 16, 2021 |
| Vieser Jaime | — | Purchase | 100,000 | $1.91 | $191,000 | 705,321 | Sep 29, 2021 |
| Hagen Heidi | — | Purchase | 23,770 | $1.76 | $41,835 | 145,889 | Sep 2, 2021 |
| Postma Robert W | — | Purchase | 54,492 | $1.73 | $94,271 | 4,250,000 | Sep 2, 2021 |
| Weis Holger | — | Purchase | 50,000 | $1.83 | $91,500 | 120,167 | Sep 1, 2021 |
| Huang James | — | Purchase | 100,000 | $1.71 | $171,000 | 108,333 | Sep 1, 2021 |
| Boyle Kevin S. Sr. | Chief Executive Officer | Award / Grant | 875,000 | — | — | 875,000 | Aug 30, 2021 |
| Baffa Raffaele | Chief Medical Officer | Award / Grant | 80,645 | — | — | 280,645 | May 17, 2021 |
| Buck Jill | EVP, GM Gene Therapy | Award / Grant | 31,500 | — | — | 231,016 | Mar 4, 2021 |
| Hadfield Robert | Chief Legal Officer and Sec. | Award / Grant | 43,500 | — | — | 176,819 | Mar 4, 2021 |
| Hagen Heidi | Interim CEO | Award / Grant | 90,000 | — | — | 122,119 | Mar 4, 2021 |
| De Groot Eleanor | EVP, GM Cell Therapy | Award / Grant | 50,825 | — | — | 257,238 | Mar 4, 2021 |
| BUCHI J KEVIN | — | Award / Grant | 4,167 | — | — | 4,167 | Mar 4, 2021 |
| Weis Holger | — | Award / Grant | 4,167 | — | — | 70,167 | Mar 4, 2021 |
| Vieser Jaime | — | Award / Grant | 4,167 | — | — | 605,321 | Mar 4, 2021 |
| Thistle Mary | — | Award / Grant | 5,000 | — | — | 5,000 | Mar 4, 2021 |
| Postma Robert W | — | Award / Grant | 2,500 | — | — | 1,181,362 | Mar 4, 2021 |
| Huang James | — | Award / Grant | 8,333 | — | — | 8,333 | Mar 4, 2021 |
| Bowden Christopher | — | Award / Grant | 4,167 | — | — | 4,167 | Mar 4, 2021 |
| Buck Jill | EVP, GM Gene Therapy | Sale | 27,894 | $3.12 | $87,029 | 199,516 | Jan 8, 2021 |
| Lafond Kevin G | SVP, Treasurer & CAO | Sale | 18,020 | $3.09 | $55,682 | 63,965 | Jan 8, 2021 |
| Hadfield Robert | General Counsel and Secretary | Sale | 26,500 | $3.12 | $82,680 | 133,319 | Jan 8, 2021 |
| De Groot Eleanor | EVP, GM Cell Therapy | Sale | 21,620 | $2.72 | $58,806 | 206,413 | Jan 4, 2021 |
| Cooper Laurence James Neil | President and CEO | Sale | 105,693 | $2.71 | $286,428 | 1,799,280 | Jan 4, 2021 |
| Shukla Sath | EVP, Chief Financial Officer | Award / Grant | 80,500 | — | — | 80,500 | Jan 29, 2020 |
| MAUNEY DAVID M MD | President | Award / Grant | 80,500 | — | — | 275,778 | Jan 29, 2020 |